Group One Trading’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-214
Closed -$4.32K 7518
2026
Q1
$4.19K Sell
214
-1,527
-88% -$37.4K ﹤0.01% 6782
2025
Q4
$46.6K Sell
1,741
-330
-16% -$8.5K ﹤0.01% 5656
2025
Q3
$55.2K Buy
+2,071
New +$53.5K ﹤0.01% 5874
2024
Q3
Sell
-814
Closed -$35.7K 6586
2024
Q2
$32.6K Buy
+814
New +$33.7K ﹤0.01% 4856
2023
Q3
Sell
-394
Closed -$21.5K 7598
2023
Q2
$22.6K Buy
394
+294
+294% +$13K ﹤0.01% 5909
2023
Q1
$3.75K Buy
+100
New +$3.28K ﹤0.01% 6404
2022
Q3
Sell
-3,826
Closed -$125K 7494
2022
Q2
$133K Buy
3,826
+1,326
+53% +$47.3K ﹤0.01% 4706
2022
Q1
$90K Buy
+2,500
New +$70.9K ﹤0.01% 5583
2021
Q3
Sell
-100
Closed -$2K 8117
2021
Q2
$2K Buy
+100
New +$1.88K ﹤0.01% 7917
2017
Q3
Sell
-801
Closed -$14K 4779
2017
Q2
$14K Sell
801
-800
-50% -$12.7K ﹤0.01% 4074
2017
Q1
$23K Buy
1,601
+300
+23% +$4.72K ﹤0.01% 3813
2016
Q4
$24K Buy
+1,301
New +$25.3K ﹤0.01% 3626

Other funds holding AMPH

Group One Trading's AMPH Position: Q2 2026 in Review

Group One Trading sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 214 shares — an estimated $4.32K sold.

Group One Trading first reported a position in AMPH in Q4 2016 and held it in 12 quarters. The position peaked at $133K in Q2 2022. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Group One Trading reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 214 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $4.32K.
  • Group One Trading first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 12 quarters.
  • Group One Trading's Amphastar Pharmaceuticals position peaked at $133K in Q2 2022.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.